Publication | Closed Access

Residual platelet activation through protease-activated receptors (PAR)-1 and ‐4 in patients on P2Y12 inhibitors

ThrombosisPlatelet Aggregation InhibitorsBlood PlateletP2y12 InhibitorsProtease-activated ReceptorsMedicinePlatelet ConcentratesImmunologyHemostasisPharmacotherapyPlatelet AntagonistPharmacologyResidual Platelet ActivationDrug DiscoveryPlatelet Activation